Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease.
Two hundred and five patients referred for evaluation of platelet functions and 126 healthy controls were tested with the PFA-100 instrument. A cut-off value of 150 s for collagen/epinephrine (CEPI) closure time (CT) produced most acceptable sensitivity (90%), specificity (85.2%), and positive (82.6%) and negative (91.6%) predictivity values for screening of platelet function disorders and von Willebrand disease (vWD). All patients with vWD and Glanzmann thrombasthenia could be detected by PFA-100. Both CEPI and collagen/adenosine diphosphate (CADP) CTs were elevated in all of these cases. Sensitivity of the device was 81.6% for patients with platelet secretion defects. CADP CT was normal in 63.9% of the patients in this subgroup. Specificity (47%) and positive predictivity (57%) of the instrument were diminished in patients with low hemoglobin concentrations. Depending on the results, an algorithm was developed for screening of platelet function disorders and vWD with PFA-100.
Buyukasik
Y
Y
Department of Hematology, Hacettepe University Medical School, Ankara, Turkey. ybuyukas@hacettepe.edu.tr
Karakus
S
S
Goker
H
H
Haznedaroglu
I C
IC
Ozatli
D
D
Sayinalp
N
N
Ozcebe
O I
OI
Dundar
S V
SV
Kirazli
S
S
D000465:Algorithms; D016022:Case-Control Studies; D003663:Decision Trees; D019719:Diagnostic Equipment; D006801:Humans; D010979:Platelet Function Tests / Q000295:instrumentation / Q000379:methods / Q000592:standards; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D013915:Thrombasthenia / Q000097:blood / Q000175:diagnosis; D014842:von Willebrand Diseases / Q000097:blood / Q000175:diagnosis*